Category: Marijuana Investments
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
Tilray surges 92% in 3 days amid marijuana rescheduling buzz. Discover how this impacts cannabis stocks and potential investor opportunities.
Why Curaleaf Stock Rocked the Market Today
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182 % for…
Rescheduling Should Send MJ And MSOS Sky High
Cannabis ETFs MJ and MSOS are surging on rescheduling speculation that Trump will reclassify marijuana as a Schedule III drug….
Editorial: Is it finally time for legal marijuana in Pennsylvania?
President Donald Trump is mulling a move on marijuana. The president said Monday his administration was considering rescheduling the substance,…
If You’d Invested $1,000 in Trulieve Cannabis (TCNNF) 3 Years Ago, Here’s How Much You’d Have Today
The price nose-dived by nearly 40%, and it was hardly the worst performer among its peer group.
Cannabis ETFs Light Up As Trump Eyes Marijuana Reclassification
Cannabis stocks and ETFs skyrocketed after Trump hinted at reclassifying marijuana. Tilray surged 35% in 2 days. Other top performers…
Trump revives weed industry’s long-shot hopes — and gives local cannabis players a lift
Tom Haren, the chair of the cannabis division at Cleveland-based Frantz Ward LLP, said rescheduling could result in a new…
Trump revives weed industry’s long-shot hopes — and gives cannabis players a lift
If marijuana is no longer considered a Schedule I controlled substance, companies that sell weed in legal markets such as…
Tilray Brands: Is TLRY Stock The Next Big Thing?
Tilray Brands is a speculative investment with a potential for high rewards driven by prospective regulatory changes. The chance of…
Green Light Ahead? A Trump Cannabis Shift Could Ignite This ETF
Detailed price information for CIBC Sustainable Conservative Balanced Solution (CSCB-NE) from The Globe and Mail including charting and trades.
Recent Comments